Daiichi, Mitsubishi Curb MR Vaccine Shipments in Response to Takeda’s Recall

January 19, 2024
Daiichi Sankyo and Mitsubishi Tanabe Pharma have started controlling the shipments of their respective freeze-dried live attenuated measles-rubella (MR) shots in Japan in a move triggered by Takeda Pharmaceutical’s voluntary recall of its MR jab. Takeda said on January 16...read more